The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Duncan Gregory Scott since 2021.
This trader's CIK number is 1831127.
At the time of last reporting, Duncan Gregory Scott was the CHIEF EXECUTIVE OFFICER of Virios Therapeutics, Inc.. (stock ticker symbol VIRI).
Also see all insider trading activities at Virios Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | VIRI | 25,000 | $31,250 | 0 | $0 | 0 | $0 |
2022 | VIRI | 7,500 | $33,900 | 0 | $0 | 0 | $0 |
2021 | VIRI | 20,675 | $124,376 | 0 | $0 | 801 | $6,247 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-08-17 | VIRI | Buy | 25,000 | 1.25 | 31,250 |
2022-05-23 | VIRI | Buy | 7,500 | 4.52 | 33,900 |
2021-12-21 | VIRI | Buy | 5,000 | 5.52 | 27,615 |
2021-04-05 | VIRI | Buy | 15,675 | 6.17 | 96,761 |
2021-01-06 | VIRI | Option Ex | 801 | 7.80 | 6,247 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER of Virios Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.